The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Non-Darwinian dynamics in therapy-induced cancer drug resistance
Open accessAbstract
The development of drug resistance, the prime cause of failure in cancer therapy, is commonly explained by the selection of resistant mutant cancer cells. However, dynamic non-genetic heterogeneity of clonal cell populations continuously produces metastable phenotypic variants (persisters), some of which represent stem-like states that confer resistance. Even without genetic mutations, Darwinian selection can expand these resistant variants, which would explain the invariably rapid emergence of stem-like resistant cells. Here, by using quantitative measurements and modelling, we show that appearance of multidrug resistance in HL60 leukemic cells following treatment with vincristine is not explained by Darwinian selection but by Lamarckian induction. Single-cell longitudinal monitoring confirms the induction of multidrug resistance in individual cells. Associated transcriptome changes indicate a lasting stress response consistent with a drug-induced switch between high-dimensional cancer attractors. Resistance induction correlates with Wnt pathway upregulation and is suppressed by β-catenin knockdown, revealing a new opportunity for early therapeutic intervention against the development of drug resistance. Many different factors contribute to the acquisition of drug resistance in cancer cells. Using single-cell analyses of leukaemia cells, the authors here provide evidence for an inductive mode of resistance, where cells express MDR1 in response to drug exposure, rather than selection of pre-existing, partially resistant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
CANALIZATION OF DEVELOPMENT AND THE INHERITANCE OF ACQUIRED CHARACTERS
WADDINGTON, C. H. (1942) · Nature · doi:10.1038/150563a0 · Cited by 3,255
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Stochasticity in gene expression: from theories to phenotypes
Kærn, M., Elston, T. C., Blake, W. J., & Collins, J. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1615 · Cited by 2,320
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Chemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyak, K. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3261 · Cited by 2,000
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
Roesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., & Herlyn, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.020 · Cited by 1,158
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102454108 · Cited by 1,147
Canalization of Development and Genetic Assimilation of Acquired Characters
WADDINGTON, C. H. (1959) · Nature · doi:10.1038/1831654a0 · Cited by 1,094
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells
Chang, H. H., Hemberg, M., Barahona, M., Ingber, D. E., & Huang, S. (2008) · Nature · doi:10.1038/nature06965 · Cited by 1,092
Self-citationP-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Sun, Y., Campisi, J., Higano, C., Beer, T. M., Porter, P., Coleman, I., True, L., & Nelson, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2890 · Cited by 793 · cited 1×
“From Eq.(3) we obtain for the steady-state ratio r* = x*L/x*H of the two populations, effluxLow and effluxHigh:”
BackgroundCell Fates as High-Dimensional Attractor States of a Complex Gene Regulatory Network
Huang, S., Eichler, G., Bar-Yam, Y., & Ingber, D. E. (2005) · Physical Review Letters · doi:10.1103/physrevlett.94.128701 · Cited by 775
Self-citationVariable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C., et al. (2013) · Science · doi:10.1126/science.1227670 · Cited by 744
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Das Thakur, M., Salangsang, F., Landman, A. S., Sellers, W. R., Pryer, N. K., Levesque, M. P., Dummer, R., McMahon, M., & Stuart, D. D. (2013) · Nature · doi:10.1038/nature11814 · Cited by 730
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
Meerbrey, K. L., Hu, G., Kessler, J. D., Roarty, K., Li, M. Z., Fang, J. E., Herschkowitz, J. I., Burrows, A. E., Ciccia, A., Sun, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019736108 · Cited by 666
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
Cohen, A. A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., Milo, R., Cohen-Saidon, C., Liron, Y., Kam, Z., et al. (2008) · Science · doi:10.1126/science.1160165 · Cited by 596
Dallas, N. A., Xia, L., Fan, F., Gray, M. J., Gaur, P., van Buren, G., Samuel, S., Kim, M. P., Lim, S. J., & Ellis, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2023 · Cited by 572
Balachandran, V. P., Cavnar, M. J., Zeng, S., Bamboat, Z. M., Ocuin, L. M., Obaid, H., Sorenson, E. C., Popow, R., Ariyan, C., Rossi, F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2438 · Cited by 521
van de Wetering, M., Oving, I., Muncan, V., Pon Fong, M. T., Brantjes, H., van Leenen, D., Holstege, F. C., Brummelkamp, T. R., Agami, R., & Clevers, H. (2003) · EMBO reports · doi:10.1038/sj.embor.embor865 · Cited by 512
Cancer stem cells versus phenotype‐switching in melanoma
Hoek, K. S., & Goding, C. R. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00757.x · Cited by 506
Brock, A., Chang, H., & Huang, S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2556 · Cited by 486
Self-citationNakasone, E. S., Askautrud, H. A., Kees, T., Park, J.-H., Plaks, V., Ewald, A. J., Fein, M., Rasch, M. G., Tan, Y.-X., Qiu, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.017 · Cited by 478
Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis
Donnenberg, V. S., & Donnenberg, A. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005276905 · Cited by 457
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Huang, S., Hölzel, M., Knijnenburg, T., Schlicker, A., Roepman, P., McDermott, U., Garnett, M., Grernrum, W., Sun, C., Prahallad, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.035 · Cited by 430
Self-citationChin, K. V., Tanaka, S., Darlington, G., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40219-6 · Cited by 393
Transcriptional regulation of ABC drug transporters
Scotto, K. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206950 · Cited by 392
Tenbaum, S. P., Ordóñez-Morán, P., Puig, I., Chicote, I., Arqués, O., Landolfi, S., Fernández, Y., Herance, J. R., Gispert, J. D., Mendizabal, L., et al. (2012) · Nature Medicine · doi:10.1038/nm.2772 · Cited by 386
Chaudhary, P. M., & Roninson, I. B. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.8.632 · Cited by 360
Huang, S. (2012) · BioEssays · doi:10.1002/bies.201100031 · Cited by 359
Self-citationBrandenberger, R., Wei, H., Zhang, S., Lei, S., Murage, J., Fisk, G. J., Li, Y., Xu, C., Fang, R., Guegler, K., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt971 · Cited by 329
Riely, G. J., Kris, M. G., Zhao, B., Akhurst, T., Milton, D. T., Moore, E., Tyson, L., Pao, W., Rizvi, N. A., Schwartz, L. H., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0560 · Cited by 287
Adaptive Response of a Gene Network to Environmental Changes by Fitness-Induced Attractor Selection
Kashiwagi, A., Urabe, I., Kaneko, K., & Yomo, T. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000049 · Cited by 271
Gene set enrichment analysis: performance evaluation and usage guidelines
Hung, J.-H., Yang, T.-H., Hu, Z., Weng, Z., & DeLisi, C. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbr049 · Cited by 266
Genotype–phenotype mapping and the end of the ‘genes as blueprint’ metaphor
Pigliucci, M. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0241 · Cited by 260
Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.
Dalton, W. S., Durie, B. G. M., Alberts, D. S., Gerlach, J. H., & Cress, A. E. (1986) · PubMed · Cited by 259
Response of human breast cancer cells to heat shock and chemotherapeutic drugs.
Ciocca, D. R., Fuqua, S. A. W., Lock-Lim, S., Toft, D. O., Welch, W. J., & McGuire, W. L. (1992) · PubMed · Cited by 243
Wnt signaling in stem and cancer stem cells
Wend, P., Holland, J. D., Ziebold, U., & Birchmeier, W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.004 · Cited by 237
Quasi-potential landscape in complex multi-stable systems
Zhou, J. X., Aliyu, M. D. S., Aurell, E., & Huang, S. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0434 · Cited by 234
Self-citationAbolhoda, A., Wilson, A. E., Ross, H., Danenberg, P. V., BURT, M. E., & Scotto, K. W. (1999) · PubMed · Cited by 231
Legrand, O., Simonin, G., Perrot, J.-Y., Zittoun, R., & Marie, J.-P. (1998) · Blood · doi:10.1182/blood.v91.12.4480 · Cited by 204
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
Baker, E. K., Johnstone, R. W., Zalcberg, J. R., & El-Osta, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208955 · Cited by 196
Nobili, S., Landini, I., Mazzei, T., & Mini, E. (2012) · Medicinal Research Reviews · doi:10.1002/med.20239 · Cited by 182
Iyer, R., & Lehnert, B. E. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00068-4 · Cited by 182
Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles
Eichler, G. S., Huang, S., & Ingber, D. E. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg307 · Cited by 180
Self-citationMultistable and multistep dynamics in neutrophil differentiation
Chang, H. H., Oh, P. Y., Ingber, D. E., & Huang, S. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-11 · Cited by 163
Self-citationBjorklund, C. C., Ma, W., Wang, Z.-Q., Davis, R. E., Kuhn, D. J., Kornblau, S. M., Wang, M., Shah, J. J., & Orlowski, R. Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180208 · Cited by 130
“Persisters”: Survival at the Cellular Level
Dawson, C. C., Intapa, C., & Jabra‐Rizk, M. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002121 · Cited by 125
Acquired resistance to drugs targeting receptor tyrosine kinases
Rosenzweig, S. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.025 · Cited by 122
Probing transcription-specific outputs of β-catenin in vivoPreprint
Valenta, T., Gay, M. H., Steiner, S. N., Draganova, K., Zemke, M., Hoffmans, R., Cinelli, P., Aguet, M., Sommer, L., & Basler, K. (2011) · Genes & Development · doi:10.1101/gad.181289.111 · Cited by 122
Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
Corrêa, S., Binato, R., Rocher, B. D., Castelo-Branco, M. T. L., Pizzatti, L., & Abdelhay, E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-303 · Cited by 106
Attolini, C. S., & Michor, F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04880.x · Cited by 106
Gene rearrangement: a novel mechanism for MDR-1 gene activation.
Mickley, L. A., Spengler, B. A., Knutsen, T. A., Biedler, J. L., & Fojo, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119362 · Cited by 96
The Origin of Phenotypic Heterogeneity in a Clonal Cell Population In Vitro
Stockholm, D., Benchaouir, R., Picot, J., Rameau, P., Neildez‐Nguyen, T. M. A., Landini, G., Laplace‐Builhé, C., & Páldi, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000394 · Cited by 94
Notarbartolo, M., Cervello, M., Dusonchet, L., Cusimano, A., & D’Alessandro, N. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00834-5 · Cited by 92
Gene Expression Noise Facilitates Adaptation and Drug Resistance Independently of Mutation
Charlebois, D. A., Abdennur, N. A., & Kærn, M. (2011) · Physical Review Letters · doi:10.1103/physrevlett.107.218101 · Cited by 86
On the intrinsic inevitability of cancer: From foetal to fatal attraction
Huang, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.05.003 · Cited by 86
Self-citationTumor progression: Chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution
Huang, S. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.05.001 · Cited by 82
Self-citationTenbaum, S. P., Ordóñez‐Morán, P., Puig, I., Chicote, I., Arqués, O., Vivancos, A. P., Baselga, J. M., Tabernero, J. M., Munoz, A., & Pálmer, H. G. (2012) · European Journal of Cancer · doi:10.1016/s0959-8049(12)71330-8 · Cited by 50
Öğretmen, B., & Safa, A. R. (1999) · Biochemistry · doi:10.1021/bi991943f · Cited by 49
Lee, G., Shim, J., Cho, B., Jung, J., Lee, D.-S., & Oh, I. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0734-2 · Cited by 20
Lee (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr816e · Cited by 7
Cited by
Glioblastoma Stem Cells: Driving Resilience through Chaos
Prager, B. C., Bhargava, S., Mahadev, V., Hubert, C. G., & Rich, J. N. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.009 · Cited by 401
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
Rambow, F., Marine, J.-C., & Goding, C. R. (2019) · Genes & Development · doi:10.1101/gad.329771.119 · Cited by 325
Persistent Cancer Cells: The Deadly Survivors
Shen, S., Vagner, S., & Robert, C. (2020) · Cell · doi:10.1016/j.cell.2020.10.027 · Cited by 304
Pisco, A. O., & Huang, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.146 · Cited by 283
Self-citationEmerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
Metadata
- Authors
- Pisco, A. O., Brock, A., Zhou, J., Moor, A., Mojtahedi, M., Jackson, D., & Huang, S.
- Venue
- Nature Communications
- Published
- 2013-09-18
- Volume
- 4
- Issue
- 1
- Pages
- 2467-2467
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2171642372
- Cited by
- 297
- References
- 69
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.